Your browser doesn't support javascript.
Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?
MohanaSundaram, ArunSundar; Thukani Sathanantham, Shanmugarajan; Sveikata, Lukas; Lalla, Rakesh Shyam; Sveikatiene, Renata; Kaushik, Ajeet; Velayutham, Ravichandiran.
  • MohanaSundaram A; School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, India.
  • Thukani Sathanantham S; School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, India.
  • Sveikata L; Department of Neurology, Massachusetts General Hospital,Harvard Medical School, Boston, Massachusetts, USA.
  • Lalla RS; Institute of Cardiology, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Sveikatiene R; Department of Neurology, Fortis Hospital, Kalyan, India.
  • Kaushik A; Institute of Physiology and Pharmacology, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Velayutham R; NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, Florida, USA.
Expert Rev Neurother ; 22(4): 283-286, 2022 04.
Article in English | MEDLINE | ID: covidwho-1740637

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alzheimer Disease / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Expert Rev Neurother Journal subject: Neurology / Therapeutics Year: 2022 Document Type: Article Affiliation country: 14737175.2022.2053112

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Alzheimer Disease / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Expert Rev Neurother Journal subject: Neurology / Therapeutics Year: 2022 Document Type: Article Affiliation country: 14737175.2022.2053112